Top

Molecular Diagnosis & Therapy

Published in:

01-06-2013 | Review Article

Systematic Review of the Evidence of a Relationship Between Chronic Psychosocial Stress and C-Reactive Protein

Authors: Timothy V. Johnson, Ammara Abbasi, Viraj A. Master

Published in: Molecular Diagnosis & Therapy | Issue 3/2013

Abstract

Introduction

C-reactive protein (CRP) is an acute-phase reactant with an increasing number of clinical functions. Studies in recent years have identified several social, economic, demographic, and psychological factors that contribute to baseline inflammation. Psychosocial stress represents a significant contributor to baseline inflammation. Given the importance of understanding background drivers of CRP levels, we conducted this review to assess the impact of chronic psychosocial stress on CRP levels.

Methods

Medline was searched through February 2013 for human studies examining CRP levels with respect to chronic psychosocial stress.

Results

The initial search identified 587 articles from which 129 potentially appropriate articles were reviewed. Of these 129 articles, 41 articles were included in the review. These studies were published between 2003 and 2013. Of these studies, 6 analyzed employment stress, 2 analyzed unemployment stress, 6 analyzed burnout and vital exhaustion, 6 analyzed caregiver stress, 3 analyzed interpersonal stress, 17 analyzed socioeconomic position, and 2 analyzed discrimination.

Conclusion

We conclude that psychosocial stress significantly impacts CRP and should be considered when interpreting the meaning of CRP elevations.

Steptoe A, Hamer M, Chida Y. The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis. Brain Behav Immun. 2007;21:901–12.PubMed

Jabs WJ, Busse M, Kruger S, Jocham D, Steinhoff J, Doehn C. Expression of C-reactive protein by renal cell carcinomas and unaffected surrounding renal tissue. Kidney Int. 2005;68(5):2103–10.PubMed

Brull DJ, Serrano N, Zito F, et al. Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease. Arterioscler Thromb Vasc Biol. 2003;23(11):2063–9.PubMed

Greenfield JR, Samaras K, Jenkins AB, et al. Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences. Circulation. 2004;109(24):3022–8.PubMed

Hsiao AL, Baker MD. Fever in the new millennium: a review of recent studies of markers of serious bacterial infection in febrile children. Curr Opin Pediatr. 2005;17(1):56–61.PubMed

Johnson HL, Chiou CC, Cho CT. Applications of acute phase reactants in infectious diseases. J Microbiol Immunol Infect. 1999;32(2):73–82.PubMed

Johnson T, Young A, Osunkoya A, Master V. C-reactive protein: a clinically useful biomarker for metastasis of renal cell carcinoma. Mol Diagn Ther. 2010;14:191–3.PubMed

Johnson TV, Abbasi A, Owen-Smith A, et al. Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma. J Urol. 2010;183(2):480–5.PubMed

Johnson TV, Abbasi A, Owen-Smith A, et al. Postoperative better than preoperative C-reactive protein at predicting outcome after potentially curative nephrectomy for renal cell carcinoma. Urology. 2010;76:766.e1–5.

10.

Ford ES, Loucks EB, Berkman LF. Social integration and concentrations of C-reactive protein among US adults. Ann Epidemiol. 2006;16(2):78–84.PubMed

11.

Friedman EM, Hayney MS, Love GD, et al. Social relationships, sleep quality, and interleukin-6 in aging women. Proc Natl Acad Sci U S A. 2005;102(51):18757–62.PubMed

12.

Nazmi A, Victora CG. Socioeconomic and racial/ethnic differentials of C-reactive protein levels: a systematic review of population-based studies. BMC Public Health. 2007;7:212.PubMed

13.

Cohen S, Kessler R, Gordon L. Strategies for measuring stress in studies of psychiatric and physical disorders. In: Cohen S, Kessler R, Gordon L, editors. Measuring stress: a guide for health and social scientists. New York: Oxford University Press; 1995. p. 3–26.

14.

McEwen BS. Protection and damage from acute and chronic stress: allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Ann N Y Acad Sci. 2004;1032:1–7.PubMed

15.

Reiche EM, Nunes SO, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol. 2004;5(10):617–25.PubMed

16.

Everson-Rose SA, Lewis TT. Psychosocial factors and cardiovascular diseases. Annu Rev Public Health. 2005;26:469–500.PubMed

17.

Festa A, D’Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation. 2000;102(1):42–7.PubMed

18.

Bailey MT, Kierstein S, Sharma S, et al. Social stress enhances allergen-induced airway inflammation in mice and inhibits corticosteroid responsiveness of cytokine production. J Immunol. 2009;182(12):7888–96.PubMed

19.

Rozanski A, Blumenthal J, Davidson K, Saab P, Kubzansky L. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice. J Am Coll Cardiol. 2005;45(5):637–51.PubMed

20.

Karasek R, Baker D, Marxer F, Ahlbom A, Theorrel T. Job decision latitude, job demands, and cardiovascular disease: a prospective study of Swedish men. Am J Public Health. 1981;71:694–705.PubMed

21.

Hemingway H, Marmot M. Evidence based cardiology: psychosocial factors in the aetiology and prognosis of coronary heart disease. Systematic review of prospective cohort studies. BMJ. 1999;318(7196):1460–7.PubMed

22.

Siegrist J. Adverse health effects of high-effort/low-reward conditions. J Occup Health Psychol. 1996;71:694–705.

23.

Kuper H, Singh-Manoux A, Siegrist J, Marmot M. When reciprocity fails: effort-reward imbalance in relation to coronary heart disease and health functioning within the Whitehall II study. Occup Environ Med. 2002;59(11):777–84.PubMed

24.

Johnson JV, Hall EM, Theorell T. Combined effects of job strain and social isolation on cardiovascular disease morbidity and mortality in a random sample of the Swedish male working population. Scand J Work Environ Health. 1989;15(4):271–9.PubMed

25.

Kivimaki M, Leino-Arjas P, Luukkonen R, Riihimaki H, Vahtera J, Kirjonen J. Work stress and risk of cardiovascular mortality: prospective cohort study of industrial employees. BMJ. 2002;325(7369):857.PubMed

26.

Johnson JV, Stewart W, Hall EM, Fredlund P, Theorell T. Long-term psychosocial work environment and cardiovascular mortality among Swedish men. Am J Public Health. 1996;86(3):324–31.PubMed

27.

Peter R, Siegrist J, Hallqvist J, Reuterwall C, Theorell T. Psychosocial work environment and myocardial infarction: improving risk estimation by combining two complementary job stress models in the SHEEP Study. J Epidemiol Community Health. 2002;56(4):294–300.PubMed

28.

Emeny R, Lacruz ME, Baumert J, et al. Job strain associated CRP is mediated by leisure time physical activity: results from the MONICA/KORA study. Brain Behav Immun. 2012;26(7):1077–84.PubMed

29.

Marmot MG, Bosma H, Hemingway H, Brunner E, Stansfeld S. Contribution of job control and other risk factors to social variations in coronary heart disease incidence. Lancet. 1997;350(9073):235–9.PubMed

30.

Lynch J, Krause N, Kaplan GA, Salonen R, Salonen JT. Workplace demands, economic reward, and progression of carotid atherosclerosis. Circulation. 1997;96(1):302–7.PubMed

31.

Muntaner C, Nieto FJ, Cooper L, Meyer J, Szklo M, Tyroler HA. Work organization and atherosclerosis: findings from the ARIC study. Atherosclerosis Risk in Communities. Am J Prev Med. 1998;14(1):9–18.PubMed

32.

Nordstrom CK, Dwyer KM, Merz CN, Shircore A, Dwyer JH. Work-related stress and early atherosclerosis. Epidemiology. 2001;12(2):180–5.PubMed

33.

Bosma H, Marmot MG, Hemingway H, Nicholson AC, Brunner E, Stansfeld SA. Low job control and risk of coronary heart disease in Whitehall II (prospective cohort) study. BMJ. 1997;314(7080):558–65.PubMed

34.

Schnorpfeil P, Noll A, Schulze R, Ehlert U, Frey K, Fischer JE. Allostatic load and work conditions. Soc Sci Med. 2003;57(4):647–56.PubMed

35.

Clays E, De Bacquer D, Delanghe J, Kittel F, Van Renterghem L, De Backer G. Associations between dimensions of job stress and biomarkers of inflammation and infection. J Occup Environ Med. 2005;47(9):878–83.PubMed

36.

Bellingrath S, Weigl T, Kudielka BM. Chronic work stress and exhaustion is associated with higher allostastic load in female school teachers. Stress. 2009;12(1):37–48.PubMed

37.

Almadi T, Cathers I, Hamdan Mansour AM, Chow CM. The association between work stress and inflammatory biomarkers in Jordanian male workers. Psychophysiology. 2012;49(2):172–7.PubMed

38.

Hemingway H, Shipley M, Mullen MJ, et al. Social and psychosocial influences on inflammatory markers and vascular function in civil servants (the Whitehall II study). Am J Cardiol. 2003;92(8):984–7.PubMed

39.

Poanta L, Craciun A, Dumitrascu DL. Professional stress and inflammatory markers in physicians. Rom J Intern Med. 2010;48(1):57–63.PubMed

40.

Hintikka J, Lehto SM, Niskanen L, et al. Unemployment and ill health: a connection through inflammation? BMC Public Health. 2009;9:410.PubMed

41.

Cook DG, Cummins RO, Bartley MJ, Shaper AG. Health of unemployed middle-aged men in Great Britain. Lancet. 1982;1(8284):1290–4.PubMed

42.

Hammarstrom A. Health consequences of youth unemployment. Public Health. 1994;108(6):403–12.PubMed

43.

Leino-Arjas P, Liira J, Mutanen P, Malmivaara A, Matikainen E. Predictors and consequences of unemployment among construction workers: prospective cohort study. BMJ. 1999;319(7210):600–5.PubMed

44.

Breslin FC, Mustard C. Factors influencing the impact of unemployment on mental health among young and older adults in a longitudinal, population-based survey. Scand J Work Environ Health. 2003;29(1):5–14.PubMed

45.

Janicki-Deverts D, Cohen S, Matthews KA, Cullen MR. History of unemployment predicts future elevations in C-reactive protein among male participants in the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Ann Behav Med. 2008;36(2):176–85.PubMed

46.

Toker S, Shirom A, Shapira I, Berliner S, Melamed S. The association between burnout, depression, anxiety, and inflammation biomarkers: C-reactive protein and fibrinogen in men and women. J Occup Health Psychol. 2005;10(4):344–62.PubMed

47.

Danhof-Pont MB, van Veen T, Zitman FG. Biomarkers in burnout: a systematic review. J Psychosom Res. 2011;70(6):505–24.PubMed

48.

Appels A. Vital exhaustion as a precursor of myocardial infarction. New York: Wiley; 1988.

49.

Appels A, Schouten E. Burnout as a risk factor for coronary heart disease. Behav Med. 1991;17(2):53–9.PubMed

50.

Hallman T, Thomsson H, Burell G, Lisspers J, Setterlind S. Stress, burnout and coping: differences between women with coronary heart disease and healthy matched women. J Health Psychol. 2003;8(4):433–45.PubMed

51.

Melamed S, Shirom A, Froom P. Burnout and risk of type 2 diabetes mellitus in Israeli workers. Toronto: Work, Stress and Health Conference; 2003.

52.

Sheiner EK, Sheiner E, Carel R, Potashnik G, Shoham-Vardi I. Potential association between male infertility and occupational psychological stress. J Occup Environ Med. 2002;44(12):1093–9.PubMed

53.

Halford C, Anderzen I, Arnetz B. Endocrine measures of stress and self-rated health: a longitudinal study. J Psychosom Res. 2003;55(4):317–20.PubMed

54.

Appels A, Schouten E. Waking up exhausted as risk indicator of myocardial infarction. Am J Cardiol. 1991;68(4):395–8.PubMed

55.

Gorter RC, Eijkman MA, Hoogstraten J. Burnout and health among Dutch dentists. Eur J Oral Sci. 2000;108(4):261–7.PubMed

56.

Melamed S, Kushnir T, Shirom A. Burnout and risk factors for cardiovascular diseases. Behav Med. 1992;18(2):53–60.PubMed

57.

Schaufeli W, Enzmann D. The burnout companion to study and practice: a critical analysis. Washington, DC: Taylor & Francis; 1998.

58.

Melamed S, Ugarten U, Shirom A, Kahana L, Lerman Y, Froom P. Chronic burnout, somatic arousal and elevated salivary cortisol levels. J Psychosom Res. 1999;46(6):591–8.PubMed

59.

Grossi G, Perski A, Evengard B, Blomkvist V, Orth-Gomer K. Physiological correlates of burnout among women. J Psychosom Res. 2003;55(4):309–16.PubMed

60.

Langelaan S, Bakker AB, Schaufeli WB, van Rhenen W, van Doornen LJ. Is burnout related to allostatic load? Int J Behav Med. 2007;14(4):213–21.PubMed

61.

Jonsdottir IH, Hagg DA, Glise K, Ekman R. Monocyte chemotactic protein-1 (MCP-1) and growth factors called into question as markers of prolonged psychosocial stress. PLoS One. 2009;4(11):e7659.PubMed

62.

Wirtz PH, von Kanel R, Schnorpfeil P, Ehlert U, Frey K, Fischer JE. Reduced glucocorticoid sensitivity of monocyte interleukin-6 production in male industrial employees who are vitally exhausted. Psychosom Med. 2003;65(4):672–8.PubMed

63.

Rohleder N, Marin T, Ma R, Miller G. Biologic cost of caring for a cancer patient: dysregulation of pro- and anti-inflammatory signaling pathways. J Clin Oncol. 2009;2(18):2909–15.

64.

Kim Y, Schulz R. Family caregivers’ strains: comparative analysis of cancer caregiving with dementia, diabetes, and frail elderly caregiving. J Aging Health. 2008;20(5):483–503.PubMed

65.

Kim Y, Given BA. Quality of life of family caregivers of cancer survivors: across the trajectory of the illness. Cancer. 2008;112(11 Suppl):2556–68.PubMed

66.

Northouse LL, Mood DW, Montie JE, et al. Living with prostate cancer: patients’ and spouses’ psychosocial status and quality of life. J Clin Oncol. 2007;25(27):4171–7.PubMed

67.

Braun M, Mikulincer M, Rydall A, Walsh A, Rodin G. Hidden morbidity in cancer: spouse caregivers. J Clin Oncol. 2007;25(30):4829–34.PubMed

68.

Fletcher BS, Paul SM, Dodd MJ, et al. Prevalence, severity, and impact of symptoms on female family caregivers of patients at the initiation of radiation therapy for prostate cancer. J Clin Oncol. 2008;26(4):599–605.PubMed

69.

Schulz R, Beach SR. Caregiving as a risk factor for mortality: the Caregiver Health Effects Study. JAMA. 1999;282(23):2215–9.PubMed

70.

Lee S, Colditz GA, Berkman LF, Kawachi I. Caregiving and risk of coronary heart disease in U.S. women: a prospective study. Am J Prev Med. 2003;24(2):113–9.PubMed

71.

Christakis NA, Allison PD. Mortality after the hospitalization of a spouse. N Engl J Med. 2006;354(7):719–30.PubMed

72.

Rohleder N, Marin TJ, Ma R, Miller GE. Biologic cost of caring for a cancer patient: dysregulation of pro- and anti-inflammatory signaling pathways. J Clin Oncol. 2009;27(18):2909–15.PubMed

73.

Miller GE, Chen E, Sze J, et al. A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling. Biol Psychiatry. 2008;64(4):266–72.PubMed

74.

Lovell B, Moss M, Wetherell M. The psychosocial, endocrine and immune consequences of caring for a child with autism or ADHD. Psychoneuroendocrinology. 2012;37(4):534–42.PubMed

75.

von Kanel R, Dimsdale JE, Mills PJ, et al. Effect of Alzheimer caregiving stress and age on frailty markers interleukin-6, C-reactive protein, and D-dimer. J Gerontol A Biol Sci Med Sci. 2006;61(9):963–9.

76.

von Kanel R, Ancoli-Israel S, Dimsdale JE, et al. Sleep and biomarkers of atherosclerosis in elderly Alzheimer caregivers and controls. Gerontology. 2010;56(1):41–50.

77.

Shivpuri S, Gallo LC, Crouse JR, Allison MA. The association between chronic stress type and C-reactive protein in the multi-ethnic study of atherosclerosis: does gender make a difference? J Behav Med. 2012;35(1):74–85.PubMed

78.

Meier-Ewert HK, Ridker PM, Rifai N, et al. Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol. 2004;43(4):678–83.PubMed

79.

von Kanel R, Mills PJ, Mausbach BT, et al. Effect of Alzheimer caregiving on circulating levels of C-reactive protein and other biomarkers relevant to cardiovascular disease risk: a longitudinal study. Gerontology. 2012;58(4):354–65.

80.

von Kanel R, Ancolli-Israel S, Dimsdale J, et al. Sleep and biomarkers of atherosclerosis in elderly Alzheimer caregivers and controls. Gerontology. 2010;56:41–50.

81.

Miller GE, Rohleder N, Cole SW. Chronic interpersonal stress predicts activation of pro- and anti-inflammatory signaling pathways 6 months later. Psychosom Med. 2009;71(1):57–62.PubMed

82.

Kiecolt-Glaser JK, Newton TL. Marriage and health: his and hers. Psychol Bull. 2001;127(4):472–503.PubMed

83.

Repetti RL, Taylor SE, Seeman TE. Risky families: family social environments and the mental and physical health of offspring. Psychol Bull. 2002;128(2):330–66.PubMed

84.

Cohen S, Janicki-Deverts D, Miller GE. Psychological stress and disease. JAMA. 2007;298(14):1685–7.PubMed

85.

Mezuk B, Diez Roux AV, Seeman T. Evaluating the buffering vs. direct effects hypotheses of emotional social support on inflammatory markers: the Multi-Ethnic Study of Atherosclerosis. Brain Behav Immun. 2010;24:1294–300.PubMed

86.

Fuligni AJ, Telzer EH, Bower J, Cole SW, Kiang L, Irwin MR. A preliminary study of daily interpersonal stress and C-reactive protein levels among adolescents from Latin American and European backgrounds. Psychosom Med. 2009;71(3):329–33.PubMed

87.

Marin TJ, Martin TM, Blackwell E, Stetler C, Miller GE. Differentiating the impact of episodic and chronic stressors on hypothalamic-pituitary-adrenocortical axis regulation in young women. Health Psychol. 2007;26(4):447–55.PubMed

88.

Gilligan T. Social disparities and prostate cancer: mapping the gaps in our knowledge. Cancer Causes Control. 2005;16(1):45–53.PubMed

89.

Curry WT Jr, Barker FG 2nd. Racial, ethnic, and socioeconomic disparities in the treatment of brain tumors. J Neurooncol. 2009;93(1):25–39.PubMed

90.

McCollum L, Pincus T. A biopsychosocial model to complement a biomedical model: patient questionnaire data and socioeconomic status usually are more significant than laboratory tests and imaging studies in prognosis of rheumatoid arthritis. Rheum Dis Clin North Am. 2009;35(4):699–712.PubMed

91.

Burrows S, Laflamme L. Socioeconomic disparities and attempted suicide: state of knowledge and implications for research and prevention. Int J Inj Contr Saf Promot. 2010;17(1):23–40.PubMed

92.

Demakakos P, Nazroo J, Breeze E, Marmot M. Socioeconomic status and health: the role of subjective social status. Soc Sci Med. 2008;67(2):330–40.PubMed

93.

Hamer M, Chida Y. Associations of very high C-reactive protein concentration with psychosocial and cardiovascular risk factors in an ageing population. Atherosclerosis. 2009;206(2):599–603.PubMed

94.

Maksimovic MZ, Vlajinac HD, Radak DJ, Maksimovic JM, Marinkovic JM, Jorga JB. Association of socioeconomic status measured by education and risk factors for carotid atherosclerosis: cross-sectional study. Croat Med J. 2008;49(6):824–31.PubMed

95.

Gimeno D, Brunner EJ, Lowe GD, Rumley A, Marmot MG, Ferrie JE. Adult socioeconomic position, C-reactive protein and interleukin-6 in the Whitehall II prospective study. Eur J Epidemiol. 2007;22(10):675–83.PubMed

96.

Tabassum F, Kumari M, Rumley A, Lowe G, Power C, Strachan DP. Effects of socioeconomic position on inflammatory and hemostatic markers: a life-course analysis in the 1958 British birth cohort. Am J Epidemiol. 2008;167(11):1332–41.PubMed

97.

Brunner EJ, Kivimaki M, Witte DR, et al. Inflammation, insulin resistance, and diabetes—Mendelian randomization using CRP haplotypes points upstream. PLoS Med. 2008;5(8):e155.PubMed

98.

Loucks EB, Pilote L, Lynch JW, et al. Life course socioeconomic position is associated with inflammatory markers: the Framingham Offspring Study. Soc Sci Med. 2010;71(1):187–95.PubMed

99.

Friedman EM, Herd P. Income, education, and inflammation: differential associations in a national probability sample (the MIDUS study). Psychosom Med. 2010;72(3):290–300.PubMed

100.

Gimeno D, Ferrie JE, Elovainio M, et al. When do social inequalities in C-reactive protein start? A life course perspective from conception to adulthood in the Cardiovascular Risk in Young Finns Study. Int J Epidemiol. 2008;37(2):290–8.PubMed

101.

Gruenewald TL, Cohen S, Matthews KA, Tracy R, Seeman TE. Association of socioeconomic status with inflammation markers in black and white men and women in the Coronary Artery Risk Development in Young Adults (CARDIA) study. Soc Sci Med. 2009;69(3):451–9.PubMed

102.

Muennig P, Sohler N, Mahato B. Socioeconomic status as an independent predictor of physiological biomarkers of cardiovascular disease: evidence from NHANES. Prev Med. 2007;45(1):35–40.PubMed

103.

Holmes LM, Marcelli EA. Neighborhoods and systemic inflammation: high CRP among legal and unauthorized Brazilian migrants. Health Place. 2012;18(3):683–93.PubMed

104.

Petersen KL, Marsland AL, Flory J, Votruba-Drzal E, Muldoon MF, Manuck SB. Community socioeconomic status is associated with circulating interleukin-6 and C-reactive protein. Psychosom Med. 2008;70(6):646–52.PubMed

105.

Browning CR, Cagney KA, Iveniuk J. Neighborhood stressors and cardiovascular health: crime and C-reactive protein in Dallas, USA. Soc Sci Med. 2012;75(7):1271–9.PubMed

106.

Nazmi A, Diez Roux A, Ranjit N, Seeman TE, Jenny NS. Cross-sectional and longitudinal associations of neighborhood characteristics with inflammatory markers: findings from the multi-ethnic study of atherosclerosis. Health Place. 2010;16(6):1104–12.PubMed

107.

Kershaw KN, Mezuk B, Abdou CM, Rafferty JA, Jackson JS. Socioeconomic position, health behaviors, and C-reactive protein: a moderated-mediation analysis. Health Psychol. 2010;29(3):307–16.PubMed

108.

Williams DR, Mohammed SA. Discrimination and racial disparities in health: evidence and needed research. J Behav Med. 2009;32(1):20–47.PubMed

109.

Kung HC, Hoyert DL, Xu J, Murphy SL. Deaths: final data for 2005. Natl Vital Stat Rep. 2008;56(10):1–120.PubMed

110.

Clark R, Anderson NB, Clark VR, Williams DR. Racism as a stressor for African Americans. A biopsychosocial model. Am Psychol. 1999;54(10):805–16.PubMed

111.

Brondolo E, Rieppi R, Kelly KP, Gerin W. Perceived racism and blood pressure: a review of the literature and conceptual and methodological critique. Ann Behav Med. 2003;25(1):55–65.PubMed

112.

Lazarus R. Emotion and adaptation. New York: Oxford University Press; 1991.

113.

Lazarus RS. Toward better research on stress and coping. Am Psychol. 2000;55(6):665–73.PubMed

114.

McDade TW, Hawkley LC, Cacioppo JT. Psychosocial and behavioral predictors of inflammation in middle-aged and older adults: the Chicago health, aging, and social relations study. Psychosom Med. 2006;68(3):376–81.PubMed

115.

Paul K, Boutain D, Agnew K, Thomas J, Hitti J. The relationship between racial identity, income, stress and C-reactive protein among parous women: implications for preterm birth disparity research. J Natl Med Assoc. 2008;100(5):540–6.PubMed

116.

Cunningham TJ, Seeman TE, Kawachi I, et al. Racial/ethnic and gender differences in the association between self-reported experiences of racial/ethnic discrimination and inflammation in the CARDIA cohort of 4 US communities. Soc Sci Med. 2012;75(5):922–31.PubMed

117.

Lewis TT, Aiello AE, Leurgans S, Kelly J, Barnes LL. Self-reported experiences of everyday discrimination are associated with elevated C-reactive protein levels in older African-American adults. Brain Behav Immun. 2010;24(3):438–43.PubMed

118.

Albert MA, Ravenell J, Glynn RJ, Khera A, Halevy N, de Lemos JA. Cardiovascular risk indicators and perceived race/ethnic discrimination in the Dallas Heart Study. Am Heart J. 2008;156(6):1103–9.PubMed

119.

Moher D, Liberati A, Tetzlaff J, Altman DG; The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. PLoS Med. 2009;6(s6):e1000097. doi:10.1371/journal.pmed.1000097. http://www.prisma-statement.org.

Title: Systematic Review of the Evidence of a Relationship Between Chronic Psychosocial Stress and C-Reactive Protein
Authors: Timothy V. Johnson
Ammara Abbasi
Viraj A. Master
Publication date: 01-06-2013
Publisher: Springer International Publishing AG
Published in: Molecular Diagnosis & Therapy / Issue 3/2013
Print ISSN: 1177-1062
Electronic ISSN: 1179-2000
DOI: https://doi.org/10.1007/s40291-013-0026-7

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2013

Biomarker Testing for Ovarian Cancer: Clinical Utility of Multiplex Assays

Applications of CYP450 Testing in the Clinical Setting

Engineering Insights for Multiplexed Real-Time Nucleic Acid Sequence-Based Amplification (NASBA): Implications for Design of Point-of-Care Diagnostics

KRAS and BRAF Mutation Analysis in Colorectal Adenocarcinoma Specimens with a Low Percentage of Tumor Cells

Monitoring Aspirin and Clopidogrel Response: Testing Controversies and Recommendations

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials